Evaluation of the in vitro activity of WCK 5222 (cefepime/zidebactam) and currently available combination therapies against single- and double-carbapenemase producing Enterobacteriaceae: Expanding the zone of hope-Reference-Cited by-同舟云学术

Evaluation of the in vitro activity of WCK 5222 (cefepime/zidebactam) and currently available combination therapies against single- and double-carbapenemase producing Enterobacteriaceae: Expanding the zone of hope

Published:2020-02 Issue:2 Volume:55 Page:105863
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Avery Lindsay M.,Mullane Elias M.,Nicolau David P.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference20 articles.

1. The use of noncarbapenem β-lactams for the treatment of extended-spectrum β-lactamase infections;Tamma;Clin Infect Dis,2017

2. Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics;Zmarlicka;Infect Drug Resist,2015

3. New Delhi metallo-β-lactamase-mediated carbapenem resistance: origin, diagnosis, treatment and public health concern;Wei;Chin Med J (Engl),2015

4. Treating infections caused by carbapenemase-producing Enterobacteriaceae;Tzouvelekis;Clin Microbiol Infect,2014

5. Emergence of NDM-1-producing Enterobacteriaceae in Belgium;Bogaerts;Antimicrob Agents Chemother,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-based characterization of conjugative IncHI1B plasmid carrying carbapenemase genes blaVIM-1, blaIMP-23, and truncated blaOXA-256 in Klebsiella pneumoniae NTU107224;Infection, Genetics and Evolution;2023-06

2. Drug development concerning metallo-β-lactamases in gram-negative bacteria;Frontiers in Microbiology;2022-09-15

3. Meropenem/Vaborbactam Plus Aztreonam as a Possible Treatment Strategy for Bloodstream Infections Caused by Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae: A Retrospective Case Series and Literature Review;Antibiotics;2022-03-10

4. Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 era;European Journal of Clinical Microbiology & Infectious Diseases;2022-01-21

5. Clinical efficacy of novel combinations of older beta-lactam and beta-lactamase inhibitors: Where are the evidences?;Indian Journal of Medical Microbiology;2021-12